-
1
-
-
0345059931
-
Amlodipine increases endothelial nitric oxide by dual mechanisms
-
Berkels R, Taubert D, Bartels H, et al. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004;70:39-45.
-
(2004)
Pharmacology
, vol.70
, pp. 39-45
-
-
Berkels, R.1
Taubert, D.2
Bartels, H.3
-
2
-
-
79955932806
-
Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1
-
Sharma A, Trane A, Yu C, et al. Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1. Eur J Pharmacol 2011;659:206-12.
-
(2011)
Eur J Pharmacol
, vol.659
, pp. 206-212
-
-
Sharma, A.1
Trane, A.2
Yu, C.3
-
3
-
-
77956283047
-
CGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action
-
Francis SH, Busch JL, Corbin JD. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010;62:525-63.
-
(2010)
Pharmacol Rev
, vol.62
, pp. 525-563
-
-
Francis, S.H.1
Busch, J.L.2
Corbin, J.D.3
-
4
-
-
33644681545
-
Adrenergec agonists and antagonists
-
Brunton LL, Lazo JS, Parker KL, eds. 11th edn. New York: McGraw Hill
-
Westfall TC, Westfall DP. Adrenergec agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gillman's The pharmacological basis of therapeutics. 11th edn. New York: McGraw Hill; 2006:275.
-
(2006)
Goodman Gillman's the Pharmacological Basis of Therapeutics
, pp. 275
-
-
Westfall, T.C.1
Westfall, D.P.2
-
5
-
-
0027533361
-
Inhibition of nitric oxide synthesis by methylene blue
-
Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993;45:367-74.
-
(1993)
Biochem Pharmacol
, vol.45
, pp. 367-374
-
-
Mayer, B.1
Brunner, F.2
Schmidt, K.3
-
6
-
-
0026706436
-
Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion
-
Marczin N, Ryan US, Catravas JD. Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 1992;263:170-9.
-
(1992)
J Pharmacol Exp Ther
, vol.263
, pp. 170-179
-
-
Marczin, N.1
Ryan, U.S.2
Catravas, J.D.3
-
7
-
-
0029622971
-
Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock
-
Gachot B, Bedos JP, Veber B, et al. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med 1995;21:1027-31.
-
(1995)
Intensive Care Med
, vol.21
, pp. 1027-1031
-
-
Gachot, B.1
Bedos, J.P.2
Veber, B.3
-
8
-
-
0034084632
-
Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass
-
Pagni S, Austin EH. Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2000;119:1297-98.
-
(2000)
J Thorac Cardiovasc Surg
, vol.119
, pp. 1297-1298
-
-
Pagni, S.1
Austin, E.H.2
-
9
-
-
84873403314
-
Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: Report of four 0consecutive cases
-
Michel S, Weis F, Sodian R, et al. Use of methylene blue in the treatment of refractory vasodilatory shock after cardiac assist device implantation: report of four 0consecutive cases. J Clin Med Res 2012;4:212-15.
-
(2012)
J Clin Med Res
, vol.4
, pp. 212-215
-
-
Michel, S.1
Weis, F.2
Sodian, R.3
|